SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-057426
Filing Date
2020-05-06
Accepted
2020-05-06 16:11:45
Documents
45
Period of Report
2020-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2018621-1_8k.htm   iXBRL 8-K 25987
2 EXHIBIT 99.1 tm2018621d1_ex99-1.htm EX-99.1 100040
3 EXHIBIT 99.2 tm2018621d1_ex99-2.htm EX-99.2 43366
7 GRAPHIC tm2018621d1_ex99-2img04.jpg GRAPHIC 258223
8 GRAPHIC tm2018621d1_ex99-2img05.jpg GRAPHIC 299543
9 GRAPHIC tm2018621d1_ex99-2img08.jpg GRAPHIC 259723
10 GRAPHIC tm2018621d1_ex99-2img09.jpg GRAPHIC 279295
11 GRAPHIC tm2018621d1_ex99-2img27.jpg GRAPHIC 288229
12 GRAPHIC tm2018621d1_ex99-2img28.jpg GRAPHIC 269215
13 GRAPHIC tm2018621d1_ex99-2img29.jpg GRAPHIC 119894
14 GRAPHIC tm2018621d1_ex99-1img01.jpg GRAPHIC 3920
15 GRAPHIC tm2018621d1_ex99-2img01.jpg GRAPHIC 218861
16 GRAPHIC tm2018621d1_ex99-2img02.jpg GRAPHIC 277516
17 GRAPHIC tm2018621d1_ex99-2img03.jpg GRAPHIC 188049
18 GRAPHIC tm2018621d1_ex99-2img06.jpg GRAPHIC 338416
19 GRAPHIC tm2018621d1_ex99-2img07.jpg GRAPHIC 268556
20 GRAPHIC tm2018621d1_ex99-2img10.jpg GRAPHIC 196450
21 GRAPHIC tm2018621d1_ex99-2img11.jpg GRAPHIC 277119
22 GRAPHIC tm2018621d1_ex99-2img12.jpg GRAPHIC 150399
23 GRAPHIC tm2018621d1_ex99-2img13.jpg GRAPHIC 124455
24 GRAPHIC tm2018621d1_ex99-2img14.jpg GRAPHIC 281977
25 GRAPHIC tm2018621d1_ex99-2img15.jpg GRAPHIC 289734
26 GRAPHIC tm2018621d1_ex99-2img16.jpg GRAPHIC 202412
27 GRAPHIC tm2018621d1_ex99-2img17.jpg GRAPHIC 299557
28 GRAPHIC tm2018621d1_ex99-2img18.jpg GRAPHIC 137477
29 GRAPHIC tm2018621d1_ex99-2img19.jpg GRAPHIC 236484
30 GRAPHIC tm2018621d1_ex99-2img20.jpg GRAPHIC 291721
31 GRAPHIC tm2018621d1_ex99-2img21.jpg GRAPHIC 224018
32 GRAPHIC tm2018621d1_ex99-2img22.jpg GRAPHIC 280012
33 GRAPHIC tm2018621d1_ex99-2img23.jpg GRAPHIC 318005
34 GRAPHIC tm2018621d1_ex99-2img24.jpg GRAPHIC 198475
35 GRAPHIC tm2018621d1_ex99-2img25.jpg GRAPHIC 153668
36 GRAPHIC tm2018621d1_ex99-2img26.jpg GRAPHIC 294462
37 GRAPHIC tm2018621d1_ex99-2img30.jpg GRAPHIC 228002
  Complete submission text file 0001104659-20-057426.txt   10359007

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20200506.xsd EX-101.SCH 3192
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20200506_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20200506_pre.xml EX-101.PRE 22714
43 EXTRACTED XBRL INSTANCE DOCUMENT tm2018621-1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 20852723
SIC: 2834 Pharmaceutical Preparations